High impact company profile available at BioMarket

Natus Medical Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. The company’s patented drug discovery technologies have helped the company in expanding its pipeline portfolio.

High impact company profile available at BioMarket

Analysis of Eli Lilly’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

SenoRx Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockout technology

High impact company profile available at BioMarket

ARYx Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Javelin Pharmaceuticals is a late development stage specialty pharmaceutical company that discovers, develops and commercializes drugs and improved formulations of existing drugs that target pain management market.

High impact company profile available at BioMarket

BTG plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

The "Nordic Life Science Industry Guide 2008" is a unique CD-ROM product that contains a searchable directory of 1,500 life science companies in Scandinavia (Denmark, Norway, Finland and Sweden).

Vernalis plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Boston Scientific is one of the leading companies in less-invasive medical devices market offering more than 15,000 products in over 45 countries across the world under the four core business groups: cardiovascular, endosurgery, neuromodulation and car

High impact company profile available at BioMarket

Flamel Technologies SA: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Introgen Therapeutics (Introgen) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer. The company has been successful in developing a strong portfolio of

Somaxon Pharmaceuticals (Somaxon) is a development stage pharmaceutical company engaged in in-licensing and developing proprietary product candidates for the treatment of psychiatry and neurology disorders.

High impact company profile available at BioMarket

Iomai Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Illumina is one of the leading companies in genome and genotyping market. The company’s proprietary technology enables conversion of raw sequence data from the human genome into medically relevant information. The January 2007 acquisition of Sole

High impact company profile available at BioMarket

Analysis of Genentech’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

High impact company profile available at BioMarket

Orexigen Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Danaher is a diversified technology company engaged in designing, manufacturing and marketing of professional, medical, industrial and consumer products with strong brand names and significant market positions.

High impact company profile available at BioMarket

Advanced Medical Optics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile